Shen Yanhua, Wang Bo, Zheng Xia, Zhang Wenwen, Wu Hailan, Hei Mingyan
Neonatal Center, Beijing Children's Hospital, Capital Medical University, Beijing, China.
National Center for Children's Health, Beijing, China.
Front Pediatr. 2020 Apr 16;8:166. doi: 10.3389/fped.2020.00166. eCollection 2020.
This was a Chinese neonatal congenital myasthenic syndromes case caused by muscle skeletal receptor tyrosine kinase gene mutations, which have not been recorded in the Human Gene Mutation Database. The newborn girl had refractory respiratory failure from birth to death, and failed extubation seven times. She had two heterozygous mutations: a non-sense mutation c.2062C>T (p.Q688X) inherited from father and a missense mutation c.2324T>C (p.F775S) inherited from mother, which was predicted pathogenic and harmful by bioinformatic softwares SIFT, PolyPhen_2 and REVEL. She positively responded to Neostigmine, but her parent quitted treatment when Pyridostigmine Bromide (2 mg/kg Q12 h) had been given for 8 days. She died 2 days after she was taken home by her parents on age of 56 days.
这是一例由肌肉骨骼受体酪氨酸激酶基因突变引起的中国新生儿先天性肌无力综合征病例,该突变尚未记录在人类基因突变数据库中。这名新生女婴从出生到死亡一直患有难治性呼吸衰竭,插管失败七次。她有两个杂合突变:一个是从父亲遗传的无义突变c.2062C>T(p.Q688X),另一个是从母亲遗传的错义突变c.2324T>C(p.F775S),生物信息软件SIFT、PolyPhen_2和REVEL预测这两个突变具有致病性和有害性。她对新斯的明有阳性反应,但在溴吡斯的明(2mg/kg每12小时一次)给药8天后,其父母放弃了治疗。她在56天大时被父母带回家,两天后死亡。